The estimated Net Worth of Joel Becker is at least 941 千$ dollars as of 22 April 2022. Mr Becker owns over 507 units of Integer Corp stock worth over 351,006$ and over the last 6 years he sold ITGR stock worth over 0$. In addition, he makes 590,451$ as Pres of Cardiac Rhythm Management & Neuromodulation at Integer Corp.
Sign up
Mr Becker ITGR stock SEC Form 4 insiders trading
Mr has made over 6 trades of the Integer Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 507 units of ITGR stock worth 62,995$ on 22 April 2022.
The largest trade he's ever made was exercising 828 units of Integer Corp stock on 21 January 2022 worth over 102,879$. On average, Mr trades about 404 units every 81 days since 2019. As of 22 April 2022 he still owns at least 2,825 units of Integer Corp stock.
You can see the complete history of Mr Becker stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Joel D. Becker biography
Joel D. Becker is the Pres of Cardiac Rhythm Management & Neuromodulation at Integer Corp.
What is the salary of Mr Becker?
As the Pres of Cardiac Rhythm Management & Neuromodulation of Integer Corp, the total compensation of Mr Becker at Integer Corp is 590,451$. There are 10 executives at Integer Corp getting paid more, with Joseph Dziedzic having the highest compensation of 5,744,890$.
How old is Mr Becker?
Mr Becker is 53, he's been the Pres of Cardiac Rhythm Management & Neuromodulation of Integer Corp since . There are 12 older and 12 younger executives at Integer Corp. The oldest executive at Integer Holdings Corp is Bill Sanford, 76, who is the Independent Chairman of the Board.
Insiders trading at Integer Corp
Over the last 8 years, insiders at Integer Corp have traded over 11,995,808$ worth of Integer Corp stock and bought 28,350 units worth 1,274,625$ . The most active insiders traders include Thomas J Hook、Filippo Passerini、Martin C Maxwell. On average, Integer Corp executives and independent directors trade stock every 14 days with the average trade being worth of 717,544$. The most recent stock trade was executed by Diron Smith on 1 September 2024, trading 168 units of ITGR stock currently worth 20,874$.
What does Integer Corp do?
integer holdings corporation (nyse:itgr) is a leader in advanced medical device outsourcing (mdo) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. integer's vision is to enhance the lives of patients worldwide by being its customer's partner of choice for innovative medical technologies and services. additionally, through electrochem, an integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. the company's medical device manufacturing brands include greatbatch™ medical and lake region medical™. additional information is available at www.integer.net.
What does Integer Corp's logo look like?
Complete history of Mr Becker stock trades at Integer Corp
Integer Corp executives and stock owners
Integer Corp executives and other stock owners filed with the SEC include:
-
Joseph Dziedzic,
President, Chief Executive Officer, Director -
Joseph W. Dziedzic,
Pres, CEO & Director -
Jason Garland,
Chief Financial Officer, Executive Vice President -
Kirk Thor,
Chief Human Resource Officer, Executive Vice President -
Payman Khales,
President - Cardio and Vascular -
Jennifer Bolt,
Senior Vice President - Global Operations -
Joseph Flanagan,
Executive Vice President - Quality and Regulatory Affairs -
Jason K. Garland,
Exec. VP & CFO -
Payman Khales,
Pres of Cardio & Vascular -
Jennifer M. Bolt,
Sr. VP of Global Operations & ESG -
Joel D. Becker,
Pres of Cardiac Rhythm Management & Neuromodulation -
Bill Sanford,
Independent Chairman of the Board -
Jean Hobby,
Independent Director -
Martin Maxwell,
Independent Director -
Pamela Bailey,
Independent Director -
James Hinrichs,
Independent Director -
William Summers,
Independent Director -
Donald Spence,
Independent Director -
Filippo Passerini,
Independent Director -
Anthony Borowicz,
Senior Vice President, Strategy, Corporate Development -
Joel Becker,
President, CRM & Neuromodulation -
Margaret Carthy,
Sr. VP of Quality and Regulatory Affairs -
Kirk K. Thor,
Exec. VP & Chief HR Officer -
McAlister C. Marshall II,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Elizabeth K. Giddens,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Carter Houghton,
Pres of Portable Medical & Electrochem -
Margaret Carthy,
EVP, Qlty & Regulatory Affairs -
Jeremy Friedman,
EVP, COO -
Gary J Haire,
EVP & Chief Financial Officer -
Thomas J Hook,
President & CEO -
Declan Smyth,
Pres., Advanced Surgical, Orth -
Jose Antonio Gonzalez,
President, CRM & Neuro -
Peter H Soderberg,
Director -
Kristin Trecker,
Chief Human Resource Officer -
Timothy G Mc Evoy,
Sr. VP, Gen. Counsel & Sec. -
Thomas J Mazza,
VP, Corporate Controller -
John A Harris,
EVP, Global Ops and Manufactur -
Michael L Spencer,
Chief Ethics & Compliance Of -
Tommy P Thomas,
VP, Corporate Controller -
Diron Smith,
EVP, Chief Financial Officer -
Carter Houghton,
President, Electrochem -
Elizabeth Giddens,
SVP, General Counsel -
Jim Stephens,
President, CRM & Neuro -
Alvin Tyrone Jeffers,
Director -
Sheila Antrum,
Director -
Cheryl C Capps,
Director -
Mc Alister C Ii Marshall,
SVP, Gen Counsel & Secretary -
Andrew Senn,
SVP, Strategy and Business Dev